Despite bipartisan opposition that led to its rejection twice in 2022, Senator Richard Durbin (D-IL) has renewed his bid to enact the FDA’s controversial Mandatory Product Listing (MPL) proposal for dietary supplements.
NPA President and CEO Daniel Fabricant, Ph.D., released the following statement on the recently published study titled: Multivitamin Use and Mortality Risk in 3 Prospective US Cohorts
NPA announced its opposition to legislation introduced by Representative Frank Pallone (D-NJ) and Senator Dick Durbin (D-IL), which would grant the FDA broad authority to prohibit certain ingredients in dietary supplements without a rendering on an ingredient’s safety.
The NPA Awards salute industry pioneers and leaders for their accomplishments in science, environmental issues, advocacy, social responsibility, and the industry at large.
